According to a new technical market research report, Infusion Devices: Technologies and Global Markets (HLC071A) from BCC Research (www.bccresearch.com), the global market for infusion devices is expected to be valued at an estimated $7 billion in 2009, but increase to nearly $9.7 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 6.5%.
The largest market by region, the United States, is projected to reach nearly $4.9 billion in 2014, after increasing at a CAGR of 5.8% from its 2009 value of nearly $3.7 billion.
The European segment, which is the second-largest by region, is estimated to be valued at $2.1 billion in 2009, and to increase at a CAGR of 6.4% to reach more than $2.8 billion by 2014.
Japan has the third-largest segment of the global market. Its 5-year CAGR is projected to be 6.3%, increasing in value from $641 million in 2009 to $869 million in 2014.
The segment with the highest CAGR among the major regions of the world, Asia (excluding Japan), is expected to grow at a 12% rate, from $324 million in 2009 to $571 million in 2014.
This report focuses on infusion pumps, medical devices that allow prolonged intravenous introduction of medications, nutrients, and analgesics in both large and small quantities to patients, with the ability to precisely regulate the amounts of the substances administered. BCC also looks at associated technologies, such as needleless jet injectors, injection pens, and minibags.
Infusion pumps represent a significant portion of the global market for drug-delivery systems. The largest market is in the U.S., with 52% of market spending on infusion pumps in 2008. More than one-quarter of that amount is captured by insulin pumps, which are used to treat diabetes.
The fastest growing market over the next 5 years will be the U.S. home infusion market, which is expected to double in size during that period, due to healthcare reform and demographic changes.
This study will be of interest to the global pharmaceutical industry, drug and medical device manufacturers, drug and medical device distributors, healthcare maintenance organizations (HMOs) and hospitals, insurance underwriters, government agency regulators, government policy makers, institutional and private investors, and various patient educational communities.